Page 12 - Delaware Medical Journal - March/April 2021

Eric Kmiec, PhD (left), Director of the Gene Editing Institute, with two members of his laboratory team.
Translational Cancer Research:
Extend the Boundaries and Accelerate the Cure Nicholas Petrelli, MD; Jennifer Sims Mourtada, PhD; Eric Kmiec, PhD; Bruce Boman, MD, PhD
BRIEF SUMMARY
The Cawley Center for Translational Cancer Research (CTCR) was established in 2009 at the Helen F. Graham Cancer Center and Research Institute (HFGCCRI) at ChristianaCare. This research unit allows physicians and scientists to work side-by-side as a team of experts, identifying needs of individual patients at the bedside, bringing those problems to the lab to explore solutions, and then returning
to the bedside where those new solutions can be used to help the patient. The 7,000-square-foot laboratory space in the CTCR houses the most sophisticated equipment necessary to investigate the biochemical and molecular etiology of cancer, including a Flow Cytometer for cell analysis and sorting, Zeiss microscope for imaging live cells, Bio-Rad Protean II protein gel apparatus to detect abnormal proteins, a Tissue Culture Facility and the BIOBASE Knowledge Library database offering integrated analysis tools for drug and biomarker discovery, gene-regulation analysis, and more.
60
Del Med J | March/April 2021 | Vol. 93 | No. 2